Subject Author Posted Rep. last R. [desc] Views
Ravi 2010-04-24 06:16 5 2010-04-29 07:42 6,906
AA 2010-04-07 07:01 10 2010-04-12 07:39 22,458
mamidi.ganesh 2006-08-29 10:52 6 2010-04-09 11:58 20,824
Helmut 2010-04-06 02:58 1 2010-04-09 10:44 5,133
dixit 2010-03-21 10:19 12 2010-04-05 06:01 13,159
kev 2010-03-25 16:35 3 2010-03-26 09:42 4,473
Helmut 2010-01-11 17:14 2 2010-03-18 11:15 4,719
ioanam 2010-02-02 16:49 3 2010-02-03 12:57 5,290
yes_naresh 2009-12-28 05:44 4 2010-01-13 14:07 7,990
balakotu 2009-12-15 11:25 0   2,402
M.Vasu 2009-11-29 13:57 0   2,259
sasikumar 2008-04-03 09:19 20 2009-10-10 08:51 31,514
Nirali 2009-09-23 07:27 4 2009-10-01 09:08 12,485
yuvrajkatkar 2009-09-15 14:04 3 2009-09-18 11:55 10,100
madhurak 2009-08-28 08:47 0   2,633
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
28 visitors (0 registered, 28 guests [including 3 identified bots]).
Forum time: 08:25 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5